<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">We consider “stakeholders” to be healthcare practitioners and patients, national and international regulatory agencies or authorities, national and regional pharmacovigilance centres, non-governmental organizations, research institutions, academics, lawyers, and marketing authorization holders (i.e. pharmaceutical companies).</p>
